Literature DB >> 16458262

Cortisol circadian rhythm alterations in psychotic major depression.

Jennifer Keller1, Benjamin Flores, Rowena G Gomez, H Brent Solvason, Heather Kenna, Gordon H Williams, Alan F Schatzberg.   

Abstract

BACKGROUND: Increased hypothalamic-pituitary-adrenal axis activity is well described in psychotic depression with an emphasis on 24-hour, urinary free cortisol levels or dexamethasone suppression tests. There are limited data on cortisol levels during specific times of the day.
METHODS: Patients with depression with (PMD) and without (NPMD) psychosis and healthy control subjects were studied using rating scales of depression and psychosis and measures of HPA activity, including overnight cortisol and adrenocorticotropin levels. We used analysis of variance to determine group differences and regression analyses to assess contributions of specific measures to cortisol levels.
RESULTS: PMDs had higher cortisol during the evening hours than did NPMDs or control subjects, who did not differ from one another. Regression analyses suggest that depression and the combination of depressive and psychotic symptoms were important contributors to variance in evening cortisol.
CONCLUSIONS: PMD is associated with increased cortisol levels during the quiescent hours. Enhanced cortisol activity, particularly a higher nadir, was related to depression severity and the interaction of depressive and psychotic symptoms. This increase suggests a defect in the action of the circadian timing system and HPA axis, creating a hormonal milieu similarly seen in early Cushing's syndrome and potentially an (im)balance of mineralocorticoid and glucocorticoid receptor activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458262     DOI: 10.1016/j.biopsych.2005.10.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  55 in total

Review 1.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

Review 2.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

Review 3.  Stress and glucocorticoid receptor transcriptional programming in time and space: Implications for the brain-gut axis.

Authors:  J W Wiley; G A Higgins; B D Athey
Journal:  Neurogastroenterol Motil       Date:  2016-01       Impact factor: 3.598

Review 4.  Psychotic major depression: a benefit-risk assessment of treatment options.

Authors:  Audrey R Tyrka; Lawrence H Price; Marcelo F Mello; Andrea F Mello; Linda L Carpenter
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment.

Authors:  Linda L Carpenter; John P Carvalho; Audrey R Tyrka; Lauren M Wier; Andrea F Mello; Marcelo F Mello; George M Anderson; Charles W Wilkinson; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2007-07-27       Impact factor: 13.382

6.  Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

Authors:  Robert L Gannon; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2007-08-13       Impact factor: 4.530

Review 7.  Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis.

Authors:  Cheryl D Conrad
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

Review 8.  Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

Authors:  Mitchel A Kling; Victoria H Coleman; Jay Schulkin
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

9.  A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation.

Authors:  Melissa A Rosenkranz; Richard J Davidson; Donal G Maccoon; John F Sheridan; Ned H Kalin; Antoine Lutz
Journal:  Brain Behav Immun       Date:  2012-10-22       Impact factor: 7.217

10.  Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.

Authors:  Jennifer Keller; Lin Shen; Rowena G Gomez; Amy Garrett; H Brent Solvason; Allan Reiss; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.